|
Título:
|
Best practices in biotechnology business development : valuation, licencing, cash flow, pharmacoeconomics, market selection, communication, and intelectual property
|
|
Autores:
|
FRIEDMAN, YALI
|
|
Tipo de documento:
|
texto impreso
|
|
Editorial:
|
Washington [U.S.A.] : Logos, 2008
|
|
ISBN/ISSN/DL:
|
56140
|
|
Dimensiones:
|
186 p.
|
|
Nota general:
|
- ISBN: 978-0-9734676-0-4
|
|
Langues:
|
Inglés
|
|
Clasificación:
|
BIOTECNOLOGÍA
EMPRESAS
INDUSTRIA
MERCADO
NEGOCIOS
|
|
Resumen:
|
The biotechnology industry is growing rapidly. Every year increasing numbers of life science graduates enter the workforce, more researchers seek to commercialize their research findings, and growing numbers of biotechnology-minded business students and business professionals seek to apply their skills and knowledge to biotechnology. Some of these biotechnology workers enter existing companies, whereas others start their own companies. Regardless of their education, training, or the nature of their work, this growing constituency is challenged to learn how to operate within the biotechnology industry, while continually monitoring and managing the implications of changes in the underpinning fundamentals. Those operating within the industry - whether in biotechnology companies or in associated supportive roles - are constantly challenged to keep abreast of industry developments and understand their significance. Seeking to meet the need to understand how to practice the business of biotechnology, these best practices provide a framework upon which to understand critical issues in biotechnology business development. Experts from a wide range of disciplines have composed best practices based on their experiences and expertise, creating a vital toolbox covering a broad spectrum of topics. These best practices will enable you develop a better understanding of the key elements in these operations and empower you to better manage their implementation.
|
